Neurological Disorders Recommendations
To view Article Recommendations, you must have an active subscription.
If your access has expired, you can subscribe at $9.95 per month, the first month of your subscription will be free of charge.
If you think you should be able to access this content, please contact us.
Sign in | Subscribe | Recommend to Library
New to F1000? See this week’s top article below for a free preview of a Recommendation.
HEADS OF FACULTY
LATEST RECOMMENDATION
Niki Karavitaki and Theingi Aung, The Churchill Hospital, University of Oxford, UK. F1000 Diabetes & Endocrinology
TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]
7 Recommendations, most recent by
Dominique Ferrandon, Institut de Biologie Moléculaire et Cellulaire du CNRS, France. F1000 Immunology
- Good for Teaching
- New Finding
- Technical Advance
Past 7 Days
95
New Recommendations
11,227 total
57
New Articles Recommended
6,645 total
Past 30 Days
-
21Articles Classified As Good for Teaching231 total
-
22Articles Classified As Review / Commentary521 total
-
8Articles Classified As Controversial683 total
-
14Articles Classified As Technical Advance791 total
-
24Articles Classified As Confirmation2,456 total
-
12Articles Classified As Novel Drug Target216 total
-
43Articles Classified As Clinical Trial2,000 total
-
37Articles Classified As Interesting Hypothesis1,494 total
-
115Articles Classified As New Finding6,267 total
INDIVIDUAL SUBSCRIPTIONS
Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers, assisted by 5,000 associates, by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.
Subscribe for $9.95/monthINSTITUTIONAL SUBSCRIPTIONS
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.
Recommend to your LibrarianIf you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.
Request an Institutional Trialyour institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.

